Protalix BioTherapeutics

Manufacturing · New Jersey, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

2 University Plz Ste 100, Hackensack, Ne...

Phone Number

+972 49028100

Revenue

$84.7 Million

Stock Symbol

PLX

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Protalix BioTherapeutics

Founded in 1993 Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins. The company is headquartered in Carmiel, Isreal.Explore more
Protalix BioTherapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NYSE: PLXShow more

Protalix BioTherapeutics Org Chart

DB
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
Gilad Mamlok, Senior Vice President & Chief Financial Officer at Protalix BioTherapeutics
United States flag for contact location.

Senior Vice President & Chief Financial Offic...

PhoneEmail
YN
United States flag for contact location.

Senior Vice President and Chief Operating Off...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TA
United States flag for contact location.

Senior Controller Protalix Biotherapeutics

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Protalix BioTherapeutics

Compare insights from companies similar to Protalix BioTherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Protalix BioTherapeutics

$84.7M
201-500
Public
$78.7M
1993
DB
Dror BashanPresident & CEO
$66.4M
51-200
Private
$25M
2008
Ruby Chen-Tsai, President & Founder at Applied Stemcell
Ruby Chen-TsaiPresident & Founder
$37.2M
51-200
Private
<$5M
2001
$19.3M
51-200
Private
-
2008
KB
Kusharaj BhandaryCEO and MD, Multi Family Office
$18.3M
51-200
Private
-
2010
CH
Chin-shiou HuangVice President & Chief Technology Officer
$17.3M
51-200
Private
$71M
2014
BL
Beth LarimoreDirector of Process Sciences
$7.3M
51-200
Private
-
2000
TO
Tamlyn OliverManaging Editor
Illustration of an envelope

Protalix BioTherapeutics Tech Stack

A closer look at the technologies used by Protalix BioTherapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Protalix BioTherapeutics

What is Protalix BioTherapeutics's stock symbol?
Protalix BioTherapeutics's stock symbol is PLX
What is Protalix BioTherapeutics's official website?
Protalix BioTherapeutics's official website is www.protalix.com
What is Protalix BioTherapeutics's Revenue?
Protalix BioTherapeutics's revenue is $84.7 Million
What is Protalix BioTherapeutics's SIC code?
Protalix BioTherapeutics's SIC: 28,283
What is Protalix BioTherapeutics's NAICS code?
Protalix BioTherapeutics's NAICS: 32,325
How many employees does Protalix BioTherapeutics have?
Protalix BioTherapeutics has 201-500 employees
What industry does Protalix BioTherapeutics belong to?
Protalix BioTherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Protalix BioTherapeutics competition?
Protalix BioTherapeutics top competitors include: Just Biotherapeutics, PlexBio, Biocompare, Applied Stemcell
What technology does Protalix BioTherapeutics use?
Some of the popular technologies that Protalix BioTherapeutics uses are: Drupal, YouTube, Microsoft 365, Google Tag Manager
Who is the CFO of Protalix BioTherapeutics?
Protalix BioTherapeutics's CFO is Gilad Mamlok
How do I contact Protalix BioTherapeutics?
Protalix BioTherapeutics contact info: Phone number: +972 49028100 Website: www.protalix.com
What does Protalix BioTherapeutics do?

Founded in 1993 Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins. The company is headquartered in Carmiel, Isreal.... Read More

What are Protalix BioTherapeutics social media links?
Protalix BioTherapeutics Linkedin page Protalix BioTherapeutics Facebook page
Who invested in Protalix BioTherapeutics?
Protalix BioTherapeutics has 7 investors including More Investment House, Alrov Properties, Psagot and UBS O'Connor.
Is Protalix BioTherapeutics a public company?
Yes, Protalix BioTherapeutics is a public company and is traded under the symbol PLX
See more information about Protalix BioTherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.